GeneOne Life Science, Inc. announced a private placement of 722,218 registered common stock at a price of KRW 3,420 per share for gross proceeds of KRW 2,469,985,560 on September 6, 2023. The transaction has been approved by the board of directors of the company. The company will issue shares through paid-in capital increase allocation method.